Suppr超能文献

P2Y受体介导的Ca(2+)信号传导增加人血管内皮细胞通透性。

P2Y receptor-mediated Ca(2+) signaling increases human vascular endothelial cell permeability.

作者信息

Tanaka Naoko, Kawasaki Kumiko, Nejime Namie, Kubota Yoko, Nakamura Kazuki, Kunitomo Masaru, Takahashi Koichi, Hashimoto Michio, Shinozuka Kazumasa

机构信息

Department of Pharmacology, School of Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan.

出版信息

J Pharmacol Sci. 2004 Jun;95(2):174-80. doi: 10.1254/jphs.fpj03036x.

Abstract

We investigated the effects of P2-receptor agonists on cell size, intracellular calcium levels (Ca(2+)), and permeation of FITC-labeled dextran (FD-4) as well as the relationship between these effects in human umbilical vein endothelial cells (HUVEC). FD-4 concentration, cell size, and Ca(2+) were analyzed by HPLC with fluorescence, phase contrast microscopic imaging, and fluorescent confocal microscopic imaging, respectively. The P2Y(1)-receptor agonists 2-methylthio ATP (2meS-ATP) and ADP decreased cell size and increased Ca(2+) in HUVEC. The P2Y(2)-receptor agonist UTP increased Ca(2+), but did not influence cell size. The P2X-receptor agonist alpha,beta-methylene ATP did not induce either response. The decrease in size and increase in Ca(2+) by 2meS-ATP were blocked by pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, P2Y(1)-antagonist), thapsigargin (Ca(2+)-pump inhibitor), and U73122 (phospholipase C inhibitor). Furthermore, 2meS-ATP (P2Y(1)-receptor agonist) enhanced permeation of FD-4 through the endothelial cell monolayer. The 2meS-ATP-induced enhancement of the permeation was also prevented by PPADS, thapsigargin, and U73122. These results indicate that activation of P2Y receptors induces a decrease in cell size, an increase in Ca(2+), and may participate in facilitating macromolecular permeability in HUVEC.

摘要

我们研究了P2受体激动剂对人脐静脉内皮细胞(HUVEC)的细胞大小、细胞内钙水平([Ca(2+)]i)、FITC标记葡聚糖(FD-4)的通透作用以及这些作用之间的关系。分别采用荧光HPLC、相差显微镜成像和荧光共聚焦显微镜成像分析FD-4浓度、细胞大小和[Ca(2+)]i。P2Y(1)受体激动剂2-甲硫基ATP(2meS-ATP)和ADP可减小HUVEC的细胞大小并升高[Ca(2+)]i。P2Y(2)受体激动剂UTP可升高[Ca(2+)]i,但不影响细胞大小。P2X受体激动剂α,β-亚甲基ATP未引发上述任何一种反应。2meS-ATP导致的细胞大小减小和[Ca(2+)]i升高被磷酸吡哆醛-6-偶氮苯基-2',4'-二磺酸(PPADS,P2Y(1)拮抗剂)、毒胡萝卜素(钙泵抑制剂)和U73122(磷脂酶C抑制剂)所阻断。此外,2meS-ATP(P2Y(1)受体激动剂)可增强FD-4透过内皮细胞单层的通透作用。PPADS毒胡萝卜素和U73122也可阻止2meS-ATP诱导的通透增强作用。这些结果表明,P2Y受体的激活可导致细胞大小减小、[Ca(2+)]i升高,并可能参与促进HUVEC中大分子的通透性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验